High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Trump just opined that U.S. gross domestic product (GDP) can grow by “20%” if the Federal Reserve slashed interest rates.
Home Depot's combination of potential upside and dividends make the stock attractive.
As employers brace for a fresh round of rising healthcare costs that outpace inflation, the stakes are getting higher for companies to contain spending on treatments such as popular GLP-1 medications for weight loss.
Investing.com -- The U.S.-Iran conflict intensified over the weekend as Tehran claimed fresh attacks on a U.S.-operated drone boat and several commercial vessels, adding to a widening confrontation in the Strait of Hormuz after Washington struck three Iranian oil tankers, Al Jazeera reported on Sunday.
Companies mostly are using tariff refunds to offset inflation, but some like Walmart are lowering prices
Payroll gains of 162,000 in August may alter what the Fed does in the coming months.
Lululemon is slashing this format nearly in half by year-end as sales slump.
Americans are vibe-coding trading algorithms and handing over their stock portfolios to AI agents. Welcome to the world of the robot retail investor.
Meta Platforms Inc. CEO Mark Zuckerberg reportedly pushed back against a proposed national artificial-intelligence regulator during an August phone call with President Donald Trump, as the White House weighs a FINRA-style watchdog for frontier models. Zuckerberg Pushes Back On AI...
The chipmaker's up-to-$5 billion pledge comes with conditions attached -- and the company on the receiving end is about to get a public price.
The clause hiding inside millions of retirement portfolios.
Morgan Stanley hikes its Snowflake stock price target after a blowout quarter fueled by AI adoption and accelerating revenue growth.
Both companies are delivering impressive revenue growth.
These companies have already recorded billions in profits from their Anthropic stakes.
The ride-hailing giant exited one of its oldest markets this week, and the timing says everything.
Jerome Powell’s successor has flipped the script on inflation.
SpaceX and Tesla directors are backing academic research and a commercial venture seeking approval for MDMA-assisted therapy.
Gilead Sciences is branching out beyond its HIV franchise into oncology and immunology therapies.
Unrealized gains are lovely when they happen, but they can also turn into unrealized losses.
Sam’s Club is working hard to take business away from its biggest rival.
Carvana just posted its best quarter ever, yet the stock is down for the year.
History shows that this ETF should be a great long-term investment, regardless of any short-term noise.
Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.
Despite a solid quarter, the market seems skeptical about the fintech's future.
Lululemon shares fell 18% after weak Q2 2026 results and cut guidance revealed declining Americas sales, tepid China growth, and a fading turnaround narrative.
The August jobs report looked like a blockbuster — look inside and the story changes fast.
The Bureau of Labor Statistics reported nonfarm payrolls rose 162,000 in August, nearly three times the 55,000 consensus.
Jim Cramer went on record about Amazon stock, delivering a message worth reading.
Bank of America flagged September 11 CPI as the more decisive signal for the Fed rate path, Bitunix analysts said.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
